Search results
AMPH- A Generic Drugmaker Looking to Expand Via Acquisition, Biosimilars Moves
MoneyShow via Yahoo Finance· 2 days agoAmphastar Pharmaceuticals Inc. (AMPH) is a generic drug company founded in 1996 that went public in 2014. Amphastar focuses on drugs ...
A cheap drug may slow down aging. A study will determine if it works
NPR· 4 days agoBut Dr. Barzilai says it's been slow going to get it funded. "The main obstacle with funding this...
Mark Cuban has a simple question for CVS’s drug middleman: Why don’t you publish your prices?
Ohio Capital Journal via Yahoo News· 8 hours agoBusinessman and TV personality Mark Cuban has a seemingly straightforward question for the huge drug...
Americans could get one-time payment from $85 million generic drug settlement
The US Sun· 4 days agoDetails noted in the suit accused the two manufacturers and their affiliates of working in tandem to...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 1 day agoThe company has discontinued 12 programs, including a successor version of its immunotherapy Yervoy,...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 1 day agoDrugmakers say they price drugs to recoup years of research and development costs. They often also...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 2 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
White House Plan To Curb Drug Shortages Doesn’t Address Generics’ Quality
Forbes· 2 days agoDrug shortages are at an all-time high. The White House rolled out a plan earlier this month...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 1 hour agoDiabetes drug Farxiga rose 45%. AstraZeneca reiterated its financial guidance for 2024...quarter....
Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 12 hours agoWeaknesses Reliance on Key Products: Biogen Inc's financial health is heavily reliant on a few key products, which exposes the company to significant...